Sprout Capital VIL L.P. (Healthcare Technology Portfolio) $ amounts in millions, as of March 31, 2014 Please refer to Endnotes 1,J,K,L,M and N in this Appendix. Gross Multiple Gross Vintage Total Realized Unrealize Total (Realized Multiple Company Sector Year Cost Value d Value Value Portion) (Total) Gross IRR Adeza Biomedical Corporation Diagnostics & Infrastructure 1996 $ 48 $ 27.7 = $ - $ 27.7 5:75 575 20.1% Allos Therapeutics, Inc. Therapeutics 1998 $ 26 $ 7.5 $ - $ 75 2.87 2.87 38.8% Aradigm Corporation Therapeutics 1994 $ 28 §$ 153 $ - $ 15.3 5.45 5.45 39.3% AtheroGenics, Inc. Therapeutics 1996 $ 38 $ 71 $ - $ Zl 1.87 1.87 13.7% AviaHealth, Inc. (fka GoToMyDoc) Convergence 2000 $ 16 $ 0.0 $ - $ 0.0 0.02 0.02 -92.8% CombiChem, Ine. Therapeutics 1995 $ 39 $ 94 §$ - $ 94 2.43 2.43 26.5% Connetics Corp. (fka Connective) Therapeutics 1995 $ 63 $ 14.2 $ - $ 14.2 2.24 2.24 15.5% FemRX Healthcare Devices 1995 $ 22 $ 3.2 $ - $ 3.2 1.47 147 11.6% Healtheon/ WebMD (Sapient) Convergence 1996 $ 30 $ 39.8 §¢ - $ 39.8 13.42 13.42 190.1% Hearten Medical Healthcare Devices 1997 $ 17 $ 2 $ 2 $ m 2 = NM IntraBiotics Pharmaceuticals Therapeutics 1994 $ 39 $ 73 $ - $ 7.3 1.89 1.89 13.4% Lynx Therapeutics, Inc. Diagnostics & Infrastructure 1995 $ 11 $ 29 §¢ - $ 2.9 272. D7. 25.4% NxStage Medical, Inc. Healthcare Devices 2003 $ 33 §$ 18.9 $ - $ 18.9 5.80 5.80 20.9% Orquest, Inc. Healthcare Devices 1995 $ 55 §$ 78 $ - $ 7.8 1.42 1.42 6.1% Pathology Partners Diagnostics & Infrastructure 1997 $ 33 §$ 224 $$ - $ 20.4 6.82 6.82 38.2% Pharsight Corporation Convergence 1997 $ 49 $ 73 §$ - $ 7.3 1.48 1.48 6.0% Point Biomedical Diagnostics & Infrastructure 1997 $ 92 § 0.0 $ 2 $ 0.0 0.00 0.00 NM Prometheus Laboratories, Inc. Therapeutics 1998 $ 78 $ 388 §$ - $ 38.8 5.00 5.00 13.4% Salient Interventional Systems Healthcare Devices 1998 $ 27 § 0.0 §$ - $ 0.0 0.00 0.00 NM Skila, Inc. Convergence 1998 $ 52 §$ 02 §$ = $ 0.2 0.05 0.05 NM TriPath Imaging, Inc. Diagnostics & Infrastructure 1996 $ 49